A phase I study of paclitaxel and epirubicin, without and with filgrastim, for the treatment of platinum-resistant advanced ovarian cancer.
Lauria R, Ferrari E, Tramontana S, Morabito A, Perrone F, Maffeo A, Fiorentino R, Casella G, Iodice F, Ricchi P, Carlomagno C, Varriale E, De Placido G, De Placido S, Bianco AR, Pignata S.
Lauria R, et al.
Oncology. 1999;56(4):267-73. doi: 10.1159/000011977.
Oncology. 1999.
PMID: 10343189
Clinical Trial.